A natural PCID2-Targeting compound suppresses hepatocellular carcinoma progression: evidence from structure-based discovery and biological evaluation.

ABSTRACT:

Introduction

Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with limited therapeutic options and poor prognosis, highlighting the urgent need for novel targets and effective agents. PCID2 (PCI-domain containing protein 2) has recently been recognized as a potential therapeutic target; however, specific inhibitors remain unidentified. Natural products, particularly monomeric compounds derived from traditional Chinese medicine (TCM), provide an important source for novel anticancer candidates.

Methods

A molecular docking-based virtual screening of TCM-derived compounds were used to identify small molecules targeting PCID2. The binding interaction between the top candidate, 1,2,3,4,6-Penta-O-galloyl-β-D-glucose (β-PGG), and PCID2 was validated using surface pl

SUBMITTER: Yuemaierjiang Z 

PROVIDER: S-EPMC12698594 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature